CMRX
Price:
$0.99
Market Cap:
$88.74M
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat...[Read more]
Industry
Biotechnology
IPO Date
2013-04-11
Stock Exchange
NASDAQ
Ticker
CMRX
According to Chimerix, Inc.’s latest financial reports and current stock price. The company's current ROE is -46.35%. This represents a change of 296.30% compared to the average of -11.69% of the last 4 quarters.
The mean historical ROE of Chimerix, Inc. over the last ten years is -72.10%. The current -46.35% ROE has changed -35.72% with respect to the historical average. Over the past ten years (40 quarters), CMRX's ROE was at its highest in in the September 2022 quarter at 88.10%. The ROE was at its lowest in in the June 2022 quarter at -84.11%.
Average
-72.10%
Median
-37.05%
Minimum
-374.78%
Maximum
67.03%
Discovering the peaks and valleys of Chimerix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 552.80%
Maximum Annual ROE = 67.03%
Minimum Annual Increase = -163.45%
Minimum Annual ROE = -374.78%
Year | ROE | Change |
---|---|---|
2023 | -42.53% | -163.45% |
2022 | 67.03% | -117.88% |
2021 | -374.78% | 552.80% |
2020 | -57.41% | -63.65% |
2019 | -157.93% | 303.74% |
2018 | -39.12% | 22.23% |
2017 | -32.00% | 15.72% |
2016 | -27.66% | -20.96% |
2015 | -34.99% | 62.01% |
2014 | -21.60% | -41.61% |
The current ROE of Chimerix, Inc. (CMRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-116.76%
5-year avg
-113.13%
10-year avg
-72.10%
Chimerix, Inc.’s ROE is greater than Assembly Biosciences, Inc. (-121.55%), less than Spero Therapeutics, Inc. (20.70%), greater than Achilles Therapeutics plc (-47.36%), greater than Instil Bio, Inc. (-55.57%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than CytomX Therapeutics, Inc. (-27.44%), greater than NextCure, Inc. (-57.63%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Mereo BioPharma Group plc (-63.39%), greater than Terns Pharmaceuticals, Inc. (-39.58%),
Company | ROE | Market cap |
---|---|---|
-121.55% | $107.75M | |
20.70% | $69.72M | |
-47.36% | $42.12M | |
-55.57% | $179.70M | |
-47.64% | $8.20M | |
-27.44% | $78.90M | |
-57.63% | $36.65M | |
-22.40% | $1.49B | |
32.93% | $89.59M | |
-63.39% | $616.59M | |
-39.58% | $599.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimerix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chimerix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chimerix, Inc.'s ROE?
How is the ROE calculated for Chimerix, Inc. (CMRX)?
What is the highest ROE for Chimerix, Inc. (CMRX)?
What is the 3-year average ROE for Chimerix, Inc. (CMRX)?
What is the 5-year average ROE for Chimerix, Inc. (CMRX)?
How does the current ROE for Chimerix, Inc. (CMRX) compare to its historical average?